Marsh & McLennan upgraded to Buy from Neutral at Goldman Goldman upgraded Marsh & McLennan based on relative valuation, better than expected organic growth, and a stabilizing European outlook. Price target lowered to $40 from $43.
News For MMC From The Last 14 Days
Check below for free stories on MMC the last two weeks.